BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

552 related articles for article (PubMed ID: 16955385)

  • 41. The ratio of metastatic/resected lymph nodes is an independent prognostic factor in patients with node-positive pancreatic head cancer.
    Sierzega M; Popiela T; Kulig J; Nowak K
    Pancreas; 2006 Oct; 33(3):240-5. PubMed ID: 17003644
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pancreatic cancer patients with lymph node involvement by direct tumor extension have similar survival to those with node-negative disease.
    Williams JL; Nguyen AH; Rochefort M; Muthusamy VR; Wainberg ZA; Dawson DW; Tomlinson JS; Hines OJ; Reber HA; Donahue TR
    J Surg Oncol; 2015 Sep; 112(4):396-402. PubMed ID: 26303811
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Prognostic effect of mediastinal lymph node dissection in patients with stage I non-small cell lung cancer].
    Su XD; Wang X; Rong TH; Long H; Fu JH; Lin P; Zhang LJ; Wang SY; Wen ZS; Ma GW
    Zhonghua Wai Ke Za Zhi; 2007 Nov; 45(22):1543-5. PubMed ID: 18282391
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Number of metastatic lymph nodes, but not lymph node ratio, is an independent prognostic factor after resection of pancreatic carcinoma.
    Murakami Y; Uemura K; Sudo T; Hayashidani Y; Hashimoto Y; Nakashima A; Yuasa Y; Kondo N; Ohge H; Sueda T
    J Am Coll Surg; 2010 Aug; 211(2):196-204. PubMed ID: 20670857
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histologic characteristics enhance predictive value of American Joint Committee on Cancer staging in resectable pancreas cancer.
    Helm J; Centeno BA; Coppola D; Melis M; Lloyd M; Park JY; Chen DT; Malafa MP
    Cancer; 2009 Sep; 115(18):4080-9. PubMed ID: 19626671
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lymph node ratio: role in the staging of node-positive colon cancer.
    Wang J; Hassett JM; Dayton MT; Kulaylat MN
    Ann Surg Oncol; 2008 Jun; 15(6):1600-8. PubMed ID: 18327530
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Factors influencing aggressive therapy for bladder cancer: an analysis of data from the SEER program.
    Konety BR; Joslyn SA
    J Urol; 2003 Nov; 170(5):1765-71. PubMed ID: 14532772
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic relevance of lymph node ratio and number of resected nodes after curative resection of ampulla of Vater carcinoma.
    Falconi M; Crippa S; Domínguez I; Barugola G; Capelli P; Marcucci S; Beghelli S; Scarpa A; Bassi C; Pederzoli P
    Ann Surg Oncol; 2008 Nov; 15(11):3178-86. PubMed ID: 18712568
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An evaluation of the number of lymph nodes examined and survival for node-negative esophageal carcinoma: data from China.
    Yang HX; Xu Y; Fu JH; Wang JY; Lin P; Rong TH
    Ann Surg Oncol; 2010 Jul; 17(7):1901-11. PubMed ID: 20146101
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. Population-based study.
    Shaib Y; Davila J; Naumann C; El-Serag H
    Am J Gastroenterol; 2007 Jul; 102(7):1377-82. PubMed ID: 17403071
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Meeting the 12 lymph node (LN) benchmark in colon cancer.
    Rajput A; Romanus D; Weiser MR; ter Veer A; Niland J; Wilson J; Skibber JM; Wong YN; Benson A; Earle CC; Schrag D
    J Surg Oncol; 2010 Jul; 102(1):3-9. PubMed ID: 20578172
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lymph node metastases in patients undergoing surgery for a gallbladder cancer. Extension of the lymph node dissection and prognostic value of the lymph node ratio.
    Birnbaum DJ; Viganò L; Russolillo N; Langella S; Ferrero A; Capussotti L
    Ann Surg Oncol; 2015 Mar; 22(3):811-8. PubMed ID: 25201500
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic implications of lymph node metastases in carcinoma of the body and tail of the pancreas.
    Sahin TT; Fujii T; Kanda M; Nagai S; Kodera Y; Kanzaki A; Yamamura K; Sugimoto H; Kasuya H; Nomoto S; Takeda S; Morita S; Nakao A
    Pancreas; 2011 Oct; 40(7):1029-33. PubMed ID: 21705947
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metastatic lymph node size and colorectal cancer prognosis.
    Dhar DK; Yoshimura H; Kinukawa N; Maruyama R; Tachibana M; Kohno H; Kubota H; Nagasue N
    J Am Coll Surg; 2005 Jan; 200(1):20-8. PubMed ID: 15631916
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Results of extensive surgery for pancreatic carcinoma.
    Nagakawa T; Nagamori M; Futakami F; Tsukioka Y; Kayahara M; Ohta T; Ueno K; Miyazaki I
    Cancer; 1996 Feb; 77(4):640-5. PubMed ID: 8616755
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pattern of lymph node metastasis spread in pancreatic cancer.
    Kanda M; Fujii T; Nagai S; Kodera Y; Kanzaki A; Sahin TT; Hayashi M; Yamada S; Sugimoto H; Nomoto S; Takeda S; Morita S; Nakao A
    Pancreas; 2011 Aug; 40(6):951-5. PubMed ID: 21441841
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment.
    de Jong MC; Nathan H; Sotiropoulos GC; Paul A; Alexandrescu S; Marques H; Pulitano C; Barroso E; Clary BM; Aldrighetti L; Ferrone CR; Zhu AX; Bauer TW; Walters DM; Gamblin TC; Nguyen KT; Turley R; Popescu I; Hubert C; Meyer S; Schulick RD; Choti MA; Gigot JF; Mentha G; Pawlik TM
    J Clin Oncol; 2011 Aug; 29(23):3140-5. PubMed ID: 21730269
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors affecting axillary lymph node retrieval and assessment in breast cancer patients.
    Cil T; Hauspy J; Kahn H; Gardner S; Melnick W; Flynn C; Holloway CM
    Ann Surg Oncol; 2008 Dec; 15(12):3361-8. PubMed ID: 18830666
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lymph node evaluation in colorectal cancer patients: a population-based study.
    Baxter NN; Virnig DJ; Rothenberger DA; Morris AM; Jessurun J; Virnig BA
    J Natl Cancer Inst; 2005 Feb; 97(3):219-25. PubMed ID: 15687365
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
    Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.